Islets-activating protein (IAP) in Bordetella pertussis that potentiates insulin secretory responses of rats. Purification and characterization.
about
Toward a mechanism-based in vitro safety test for pertussis toxinPertussis toxin is required for pertussis vaccine encephalopathyPromotion of lipolysis in rat adipocytes by pertussis toxin: reversal of endogenous inhibition.Biphasic effect of pertussis vaccine on serum insulin in miceInduction of a novel morphological response in Chinese hamster ovary cells by pertussis toxinCapacitance measurements of exocytosis in mouse pancreatic alpha-, beta- and delta-cells within intact islets of Langerhans.Gαo represses insulin secretion by reducing vesicular docking in pancreatic beta-cells.Regulation of pancreatic β-cell function and mass dynamics by prostaglandin signaling.Augmented glucose-induced insulin release in mice lacking G(o2), but not G(o1) or G(i) proteinsInhibition of lipolysis by adenosine is potentiated with age.Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine.Evolving insights regarding mechanisms for the inhibition of insulin release by norepinephrine and heterotrimeric G proteins.Contribution of pertussis toxin to the pathogenesis of pertussis diseaseDirect modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane proteinMHC-restricted recognition of immunogenic T cell epitopes of pertussis toxin reveals determinants in man distinct from the ADP-ribosylase active siteMouse-protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis.Biological activities of crystalline pertussigen from Bordetella pertussis.Crystallization of pertussigen from Bordetella pertussis.Immune suppression and induction of gamma interferon by pertussis toxin.Separation and purification of the hemagglutinins from Bordetella pertussis.Novel biological property of pertussis toxin: chemotactic activity on human monocytes.G proteins Gαi1/3 are critical targets for Bordetella pertussis toxin-induced vasoactive amine sensitization.Pertussis toxin differentiates between two mechanisms of attenuation of cyclic AMP accumulation by muscarinic cholinergic receptors.Bacterial toxins and the role of ADP-ribosylation.Islet-activating protein blocks glucagon desensitization in intact hepatocytes.LH release is facilitated by agents that alter cyclic AMP-generating system.Bordetella pertussis-induced hyperinsulinaemia without marked hypoglycaemia: a paradox explainedThe relationship between pertussis-toxin-induced ADP-ribosylation of a plasma-membrane protein and reversal of muscarinic inhibition of prolactin secretion in GH3 cells.Protein-chemical analysis of pertussis toxin reveals homology between the subunits S2 and S3, between S1 and the A chains of enterotoxins of Vibrio cholerae and Escherichia coli and identifies S2 as the haptoglobin-binding subunit.Pathogen manipulation of host metabolism: A common strategy for immune evasion.Identification of Gangliosides as Inhibitors of ADP-ribosyltransferases of Pertussis Toxin and Exoenzyme C3 fromClostridium botulinum
P2860
Q26861669-A7752A6A-252C-4459-B90C-2791C2ACA917Q30449680-13854EF7-DD8C-42F4-A08E-07156DCE0037Q30449717-DD8D53E9-6560-44FE-88C1-2ACDBC87B542Q30450493-4BE76BC9-02BC-44A5-9B46-488B269C0ABCQ30450495-CCEA1772-66C6-4711-ACE7-3AC2A5F69426Q33198296-1C994B6B-753E-41B9-959B-C9C1CADCF870Q33630239-C86F0A91-FABA-4BF2-B9CA-AD470B6081C0Q33714751-38C299F2-022C-463C-B886-B01FAB25E610Q34534102-AEFF9145-76E6-4E3B-8EA1-18A61DD46900Q34619797-BD3CBE9B-8DB0-4EEE-90AA-6423231718CCQ35107603-64D57DCB-B79A-4681-BDDA-BA09B6255228Q36041923-DD829DA7-3004-4E7D-8E13-4D23820E026DQ36226458-4EAB0D5A-CE5A-46DF-BFAF-EF24E727A096Q36295605-0AE4D8D2-7B5C-4771-B639-B36562AA2071Q36355620-88A1569E-F245-473B-94ED-52DFAE6CFEFDQ36422760-4A39787F-14FF-4C40-8283-E30EBB63D3D5Q36427443-8D9CDAC1-CD4C-4531-A4B4-8C8344AC6CFEQ36455629-BE79B6A2-410E-49AC-9EA2-33070D7D0E1EQ37050942-2D300C3E-2439-4FDB-B69A-DDA69A71CE83Q37109773-D4586D54-C8EC-49EA-9D3E-FB90AB573D61Q37110061-EFD01B60-E36A-4525-9810-9D51D45353D7Q37546346-C5819D43-CAB9-4CBB-8014-49789FD51F38Q37567699-37811CD6-AADB-47C6-ABD2-5CBB428D1822Q39503017-F88384D7-D2FB-46DB-A490-40E8360D9D03Q42202952-E6801D95-D421-4F14-854F-76343F033228Q42453819-D84A6374-4E6B-494E-B8F2-5D5B145A51ACQ42619402-1613E906-7CD5-48A3-9C47-FAF612611776Q42848486-5D7422CB-8E3C-4B3E-A9CF-FFAAE3DAF16EQ45045481-05276D51-934F-413F-B910-609BE01441F7Q47114024-45665A19-9901-4DE5-ABE7-9764A88C09F4Q57064466-C0E6B548-3701-465A-8A86-10E66DF1500E
P2860
Islets-activating protein (IAP) in Bordetella pertussis that potentiates insulin secretory responses of rats. Purification and characterization.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Islets-activating protein (IAP ...... fication and characterization.
@en
type
label
Islets-activating protein (IAP ...... fication and characterization.
@en
prefLabel
Islets-activating protein (IAP ...... fication and characterization.
@en
P2093
P1476
Islets-activating protein (IAP ...... fication and characterization.
@en
P2093
Kanbayashi Y
Mizushima Y
Nakamura T
Nogimori K
P304
P356
10.1093/OXFORDJOURNALS.JBCHEM.A131904
P577
1978-01-01T00:00:00Z